Valneva SE
LSE:0OB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Valneva SE
LSE:0OB3
|
FR |
|
M
|
Mitie Group PLC
OTC:MITFF
|
UK |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
Five Star Bancorp
NASDAQ:FSBC
|
US |
|
L
|
L'Oreal SA
XMUN:LORA
|
FR |
|
C
|
Cardinal Health Inc
DUS:CLH
|
US |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
D
|
Digital Daesung Co Ltd
KOSDAQ:068930
|
KR |
|
Mistral Iberia Real Estate Socimi SA
MAD:YMIB
|
ES |
|
Abl Group ASA
F:26Q
|
NO |
Intrinsic Value
Is 0OB3 undervalued or overvalued?
See the intrinsic value estimate for 
Valneva SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
0OB3 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 0OB3’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Valneva Does
Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.
- Headquarters
- France FR
- Employees
- 674
- IPO date
- Jun 28, 2007
Revenue & Expenses Breakdown
Valneva SE
Earnings Waterfall
Valneva SE
The intrinsic value for Valneva SE (0OB3) under the Base Case is hidden EUR.
Compared with the current market price of 2.47 EUR, the stock appears hidden.